Flu

Children with obesity, asthma, and gastrointestinal disease had longer durations of stays compared with children without comorbidities.

Increased global capacity for surveillance could help monitor seasonal influenza to reduce the risk of vaccine mismatch and inform effective interventions.

In the analysis, 34.7% of commercially insured patients with chronic obstructive pulmonary disease or asthma received an influenza vaccination.

Kristi Veis discusses the importance of flu vaccinations and the role of pharmacists in administering them.

Evidence shows that the agent is not an effective nasal decongestant.

Kristi Veis discusses the importance of flu vaccinations and the role of pharmacists in administering them.

The simultaneous doses of both vaccines compared with individual RZV and quadrivalent high-dose inactivated influenza vaccine (HD-IIV4, Fluzone; Sanofi) had similar overall safety findings.

Investigators found that electronic letter reminders were most effective for older individuals, those who were unvaccinated in the preceding season, those with cardiovascular disease, and those with diabetes.

Benefits include reducing serious health consequences, such as hospitalization and death, as well as the economic burden on health systems due to influenza infection.

Investigators state that health care providers should consider the potential use of 2 doses to increase the effectiveness against influenza B.

Investigators report the study met its primary end point, demonstrating that a single, oral dose reduced the transmission by those infected to others in their household.

The findings support current recommendations for pregnant individuals or those who might become pregnant during the influenza season, specifically those with successive pregnancies.

Investigators found a significant association for febrile seizures, but not with epilepsy.

Issues around patient safety, proper administration, and monitoring need careful consideration from pharmacists and other health care providers for vaccination efforts.

The approval enables more convenient flu immunization options for patients.

Despite the new human case, which is not known to be related to animal exposure, the CDC emphasizes that risk to the general public remains low.

Lessons can be learned from Canadian models of influenza vaccine management, including proactive patient conversations and optimal workflows.

"Risk Less. Do More." plans to partner with national, state, and local organizations to provide resources to families and communities on how to protect themselves from RSV, influenza, and COVID-19.

Researchers assess the safety, tolerability, and immunogenicity of a single combination dose to evaluate its immunogenicity against SARS-CoV-2 and influenza.

RSV and influenza vaccines demonstrated hemagglutination inhibition titers that were noninferior to those with sequential administration.

Despite the century-long period of virus evolution, 6 of the 11 primates that received a cytomegalovirus-expressed flu vaccine survived the exposure to H5N1 flu.

Proper timing and vaccine selection are crucial for optimal immune responses.

With new guidance coming for the 2024-2025 season, pharmacists must stay up to date with current vaccine recommendations.

A strong recommendation from trusted health care professionals can make a difference.

Confusing product labeling and conflicting data can create challenges for patients.

Pharmacists have become the driving force behind immunizations in the US.

Many ways exist to best serve communities and the bottom line beyond vaccine ordering and increased staffing.

The 4-in-1 respiratory diagnostic test is either a single nasopharyngeal or anterior nasal swab that can confirm or rule out SARS-CoV-2, influenza A virus, influenza B virus, and respiratory syncytial virus with a single test.

Compared to other cases, the most recent patient reported more flu-like symptoms, including cough, congestion, watery eyes, and sore throat.